General Information of DTT (ID: TT6MP2Z)

DTT Name GMCSFR-alpha (CSF2RA) DTT Info
Gene Name CSF2RA

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sargramostim DMY0M8J Bone marrow transplantation QB63.6 Approved [1]
------------------------------------------------------------------------------------
10 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
B-cell lymphoma vaccine DMBRFUQ Follicular lymphoma 2A80 Preregistration [2]
Molgramostim DM2TNJ1 Autoimmune pulmonary alveolar proteinosis CB04.31 Phase 3 [3]
Pixykine DMCA6BW Human immunodeficiency virus infection 1C62 Phase 3 [4]
AFTVac DMD3XMG Glioblastoma multiforme 2A00.0 Phase 2 [5]
GM-CSF cancer vaccine DML6PO5 Solid tumour/cancer 2A00-2F9Z Phase 2 [6]
Leukemia cancer vaccine DMIFGLY Acute myeloid leukaemia 2A60 Phase 2 [6]
Mavrilimumab DMMVFRC Rheumatoid arthritis FA20 Phase 2 [7]
Myeloma cancer vaccine DMO1XUK Multiple myeloma 2A83 Phase 2 [6]
MOR-103 DMXVIQN Multiple sclerosis 8A40 Phase 1/2 [8]
KH-901 DMR14VE Solid tumour/cancer 2A00-2F9Z Phase 1 [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Clinical Trial Drug(s)
1 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
SDZ-62-826 DMAT657 Solid tumour/cancer 2A00-2F9Z Terminated [6]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
BBT-007 DMT0X6Q Neutropenia 4B00.0 Investigative [6]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Stem cell transplantation and hematopoietic growth factors. Curr Hematol Rep. 2002 Nov;1(2):103-9.
2 Idiotypevaccinetherapy (BiovaxID) infollicularlymphomain first complete remission: Phase III clinical trial results, Journal of Clinical Oncology, Vol 27, No 18S (June 20 Supplement), 2009: 2.
3 Clinical pipeline report, company report or official report of gensci-china.
4 Phase I/II trial of PIXY321 (granulocyte-macrophage colony stimulating factor/interleukin-3 fusion protein) for treatment of inherited and acquired... Br J Haematol. 1998 Nov;103(2):304-7.
5 Phase II randomized trial of autologous formalin-fixed tumor vaccine for postsurgical recurrence of hepatocellular carcinoma. Clin Cancer Res. 2004 Mar 1;10(5):1574-9.
6 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1707).
7 Clinical pipeline report, company report or official report of MedImmune (2011).
8 MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial. Ann Rheum Dis. 2015 Jun;74(6):1058-64.
9 Effects of KH901, a tumor-specific oncolytic recombinant adenovirus, on antitumor and expressing GM-CSF in xenograft tumor models. Sichuan Da Xue Xue Bao Yi Xue Ban. 2007 Jun;38(3):386-90.